SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on April 14, 2021. The registrant is incorporated in Delaware and its common stock trades on the NASDAQ Capital Market under the symbol BSGM. The report addresses a specific corporate event occurring on the filing date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
On April 14, 2021, the Company launched PURE EP Software Version 4. This new version features enhanced signal processing capabilities. A press release was issued on the same date to announce this product update.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future performance, specific risk factors, or contingencies related to the software launch. The document focuses solely on the announcement of the new software version.
Investor Verification Checklist
- Verify the technical specifications and market reception of PURE EP Software Version 4.
- Review the full text of the press release (Exhibit 99.1) for additional details on the software capabilities.
- Check subsequent filings for any financial impact or revenue recognition related to this software launch.